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1. Introduction 
1.1 History and prevalance 
According to a revised definition introduced by the International Conference on Sarcoidosis 
in 1975, sarcoidosis is a multisystem granulomatous disorder of unknown etiology, most 
often affecting young adults, in which patients present with hilar lymphadenopathy, 
pulmonary infiltration, and skin or eye lesions. This definition has been the most accepted 
till date, although many advancements have been made to understand the pathogenesis of 
this disease.  
Sarcoidosis is a chronic granulomatous disease, which is characterized by the formation of 
non-caseating granulomas at multiple sites. It is a systemic disorder of unknown etiology, 
although multiple factors like mycobacterium, viruses like mumps and influenza, beryllium, 
zirconium, genetic predisposition, autoimmune diseases and also carcinomas, are 
considered to be responsible for its etiology. 
In the first described case of sarcoidosis 120 years ago, it was called "livid papillary 
psoriasis" by Jonathan Hutchinson. Hutchinson suspected that this was a variant of mumps. 
The patient presented with purplish skin lesions and gout and later died of renal failure.  
Sarcoidosis has been reported to occur in association with malignant tumours, either 
preceeding or following malignancy. In 1977, a study was conducted on 580 cases of 
sarcoidosis. Out of these, 7 cases were found to be associated with malignancy. But these 
authors considered that the association of sarcoidosis to malignant tumour, would be just a 
co-incidence. (Battesti JP et al., 1977)  
By 1987, 23 cases of malignancy following sarcoidosis were reported.  It was observed that 
lung and breast cancer may occur more often than other tumours after sarcoidosis. It was 
considered that the immunologic abnormalities associated with sarcoidosis may promote 
the development of certain malignant tumors. (Brincker H, 1987). Patients may rarely 
present with typical sarcoidosis occurring before, during or after the diagnosis of cancer. 
Recent studies have documented this type of cases, particularly with lymphomas, testicular 
and lung cancers, melanomas and hepatocarcinomas. As far as lung cancer is considered, 
coexistence of sarcoidosis and lung cancer in the same patient is not common, and only 29 
such cases have been reported. If bilateral mediastinal lymphadenopathy is found in a case 
of lung cancer associated with sarcoidosis, surgical tumor resection should be considered. 
It has been reported that in patients with malignant diseases, non-caseating epithelioid cell 
granulomas are occasionally found in lymph nodes draining a region containing the 
malignant tumor. These non-caseating granulomas are present at single or multiple organ 
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sites without any clinical evidence to establish the diagnosis of sarcoidosis. For such tumour 
associated sarcoid granulomas, Nickerson in 1937, gave the term ‘sarcoid reaction’ and first 
pointed out the difference between sarcoid reaction and sarcoidosis. (Pavic M, 2008) This 
was accepted later as tumor-associated histologic changes, termed ‘sarcoid reactions’ 
(Takaki et al.,2010) 
Granulomas may be found as a sarcoid reaction either within the vicinity of the tumour 
itself or within the regional lymph nodes draining that particular tumour. In some cases, 
such reactions can be seen in the non-regional lymph nodes. It was reported in 1986, that 
overall, sarcoid reactions occur in 4.4% of carcinomas, in 13.8% of patients with Hodgkin's 
disease, and in 7.3% of cases of non-Hodgkin lymphomas.  
In 1997, 5 cases of Sarcoid reaction associated with papiollary carcinoma were reported. 
Brincker reviewed data on 4020 patients with malignant tumors in a broad spectrum. He 
found that 4.4% patients with carcinomas and one 0.4% of  patients with sarcomas had 
sarcoid reactions. Sarcoid reaction may be slightly more common in patients with squamous 
cell carcinomas than in those with adenocarcinomas.  
Sarcoid reaction has been observed in association with many kinds of primary tumors and 
particularly in regional lymph nodes, even in the absence of any metastases. But it is 
observed in studies that sarcoid reaction occurred about four times more often in regional 
lymph nodes without metastases than in lymph nodes with metastases. Therefore true 
sarcoidosis may be confused with local sarcoid reactions in cancer patients. This may lead to 
misdiagnosis and insufficient treatment. In some cases sarcoidosis may also develop by a 
preceeding treatment of malignancy. Although observed that, sarcoid reaction reported in 
Hodgkin's disease and gastric adenocarcinomas, may be associated with a better prognosis. 
 In a case report, association of sarcoid reactions and hepatocellular carcinoma combining 
early gastric carcinoma was reported was seen which is  the first case of its kind (Kojima M 
et al., 1993). Granulomas may be found as a sarcoid reaction in the vicinity of regional 
lymph nodes more frequently than within the tumour itself. Sarcoid like reaction has been 
observed to be 13% in lymph nodes and 5% in spleen in patients with gastric carcinoma. In 
addition, none of them showed any symptoms or signs indicative of systemic sarcoidosis. 
(Abdel-Galiil K, 2006).Clinicians need to adapt specific diagnostic techniques to differentiate 
neoplasia from benign sarcoid reactions. However, biopsies are necessary in most of cases.   
With regard to lung cancer patients, Laurberg et al reported that 20 out of 630 patients 
(3.2%) had sarcoid reactions in the mediastinal lymph nodes. In addition, they can be found 
not only in the lymph nodes draining a region containing the malignant tumor, but also in 
the tumor itself or in non-regional tissues. Some studies have shown that sarcoid reactions 
are observed within the primary tumor in patients with lung cancer. In 2008 there were three 
reported cases of sarcoid like reactions in head and neck cancer. In 2010, first case of sarcoid 
like reaction during chemotherapy for recurrent seminoma was reported. A sarcoid-like 
reaction was suspected in 1.1% of cancer patients, but the diagnosis was confirmed in 0.6%. 
(Tanizawa K) 
In testicular cancer and lymphomas, association of sarcoidosis and sarcoid-like reactions 
have been reported. They occur either synchronously or metachronously, and may also 
occur after chemotherapy. In one such case report the importance of considering the 
diagnosis of sarcoidosis in patients with metastatic disease emphasised  the association of 
sarcoidosis with head and neck cancer.  
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2. Symptoms   
There are no early signs and symptoms of Sarcoidosis. Generalised symptoms are weight 
loss, fatigue, tiredness, weakness, sluggishness, night sweats, fever, malaise and enlarged 
lymph nodes. In about 90% of cases, Lungs are involved. Symptoms include, dyspnea, 
persistent cough  and chest pain. Radiographic findings are lung tissue thickening, enlarged 
chest lymph nodes and small nodules throughout lungs. Eyes are involved in about 20-30% 
cases, and skin in 20% cases. Skin rashes, red lumps (erythema nodosum), red lumps on the 
legs (erythema nodosum), purple skin patches.  
On the other hand, Sarcoid-like reaction is a localised reaction within tissues in the absence 
of any respiratory symptoms. A sarcoid-like reaction is often indistinguishable from 
metastases on radiological studies. Swollen lymph nodes caused by a sarcoid reaction often 
mimic metastatic lymph nodes. Thus, it is difficult to differentiate sarcoid reaction from 
lymph node metastases. Except histopathological examination, there is no useful 
examination for distinguishing them.  
Laurberg reported that the frequency of associated sarcoid reactions is 3.2% in patients with 
pulmonary neoplasms, predominantly in squamous cell carcinomas. Histologically, 
squamous cell carcinomas show a statistically significant predominance. Sarcoid 
granulomas are found scattered within the lung parenchyma as well as around the carcinoid 
tumor. The distribution of this kind of sarcoid reaction is the first description.  
3. Diagnosis  
1. ROLE OF IMAGING- It is required that the clinicians adopt non- invasive diagnostic 
methods to differentiate neoplasia from benign sarcoid reactions. The 18-
fluorodeoxyglucose (18-FDG) PET-scan has not been so successful but the adjunction of 
a [3-(18) F]-alpha-methyltyrosine ((18) F-FMT) PET-scan could be more useful. FDG-
PET has been widely used in the assessment of malignancy. It has been observed that 
the sarcoid lesions could have increased FDG activity(Daniel RP et al.,1980). 
Differentiation of sarcoidosis from the sarcoid-like reactions is not an easy step in the 
final diagnosis. Thus, FDG-PET can be used as a diagnostic tool for the final diagnosis.  
2. ROLE OF CD4 + T LYMPHOCYTES- The T- and B-lymphocyte disturbances in 
sarcoid patients may be attributed to the effects of a bacterial or viral infection 
depressing T-cell function. Mycobacteria or some of its components might be capable 
of inducing the B-cell immune response and the subsequent pathologic changes. 
1.1 Phytohemagglutinin- It has been observed that, the cultured lymphocytes from 
patients with depression of delayed-type hypersensitivity, react poorly to 
phytohemagglutinin. Thus, it has been used in the diagnosis of sarcoidosis as impaired 
cellular immunity is observed in these patients.  
1.2 Circulating factors- Other techniques used to expose immunologic defects in peripheral 
lymphocytes of patients with sarcoidosis include tests of T and B cell function, rosetie 
formation and migration inhibition. There are increased circulating immunoglobulin 
levels, increased circulating antibody levels to Epstein-Barr, herpes simplex, rubella, 
measles and parainfluenza viruses, increase antibody response to mismatched blood 
and occasional false-positive Wassermann reactions, but there is no increase in 
circulating autoantibodies. (Kazuaki Morohashi ,2003) 
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1.3 Patients with active sarcoidosis, have a depression in systemic cell-mediated immunity 
manifested by a reduction in the number of circulating T cells and impaired responses 
of these cells to antigensWhen B cell activity is increased, there is elevated serum 
immunoglobulins and the presence of autoantibodies and circulating immune 
complexes.  
1.4 Bronchoalveolar lavage has shown that the sarcoid lung is characterized by increased 
numbers of "activated" T-lymphocytes within the alveolar structures. In contrast to 
normal control cells, the lung T-lymphocytes of patients with sarcoid release the 
mediator, monocyte chemotactic factor,which probably contributes to the pathogenesis 
of sarcoidosis. The  recruitment of  blood monocytes to the lung provides cellular 
building blocks for granuloma formation  
1.5 Sarcoidosis is recognized to be a multisystem granulomatous disease characterized by 
activated, cytokine-producing T cells and macrophages at sites of inflammation. Recent 
work on the molecular structure of T cell receptor genes in sarcoidosis provide evidence 
that sarcoidosis is characterized by proliferation of T cell population at sites of 
inflammation. This is consistent with local antigen-mediated immune responses. In 
addition, cytokine production in sarcoidosis indicates that tissue inflammation is 
dominated by expression of cytokines such as interferon-gamma and interleukin-12 that 
regulate the granulomatous response. These studies offer new insight into the 
molecular mechanisms of granuloma formation in sarcoidosis and provide a framework 
for developing new therapeutic strategies for the treatment of this disease.    
1.6 VEGF has also been reported to enhance the activation and migration of monocytes 
through the Flt-1 receptor in vitro,6,7 which are key events in granuloma formation. 
Genetic studies have demonstrated a significant difference in the allele frequency at 
locus _ 813 between healthy control subjects and patients with sarcoidosis. In 
sarcoidosis patients, the less common T allele was underrepresented in the sarcoidosis 
patient population as compared to the C allele which is more common in nirmal 
patients.(Kazuaki Morohashi ,2003) 
3. KVEIM’S TEST -Worldwide figures for the Kveim-Siltzbach skin test are presented. 
They provide evidence of its specificity in various international series.  Kveim-Siltzbach 
reaction is a response to an unknown Ag(s) and there can be causes of non-specific 
reactions. In an analysis, Kveim-Siltzbach reaction sites was performed using a PCR 
technique and primers specific for 20 V beta gene families. Results of this analysis 
demonstrated a pattern of V beta expression dominated by expression of V beta 2, V 
beta 3, V beta 6, or V beta 8 to levels > 20% of total V beta gene expression in nine of 15 
individuals. (Proenca NG, 1982) Kveim test performed with G-77 antigen obtained 
from sarcoid lymph nodes. The antigen was tested in 46 patients with proved or 
suspected sarcoidosis and in 50 controls. Results were;positive in 85,1%.in patients 
undergoing treatment for more than two years,only 1out of three was positive.  In 
suspected patients with only on the skin the test was positive in 58,1%.Control group 
was however negative. (Romer FK,1985) 
4. ROLE OF ACE-Elevated levels of angiotensin-converting enzyme (ACE)  are observed 
in the sera of patients with clinically active, biopsy-proved sarcoidosis. The specificity 
of this test lies in the fact that patients with dormant sarcoidosis and those with various 
other disorders have  normal levels. Elevated levels can also be seen in some cases 
representing sarcoid variants and some cases each of leprosy, carcinoma, tuberculosis, 
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lymphomatoid granulomatosis, and immunoblastic sarcoma. Although ACE is 
sensitive to active sarcoidosis, the presence of false-positive findings limits its 
diagnostic usefulness to an adjunctive role; the assay should be combined with medical 
evaluation and tissue biopsy in selected cases. (Romer FK,1980)  
A review is given on S-angiotensin-converting enzyme (SACE) and its clinical value, based 
upon 327 sarcoidosis patients and 1,274 patients with various disorders. SACE was elevated 
in 55% of the sarcoidosis patients, although with a higher frequency in those with active 
disease. In non-sarcoid patients, elevated SACE was observed in only 10 cases. The 
sensitivity and specificity were 0.55 and 0.99, respectively, and the positive and negative 
predictive values were 0.95 and 0.90, respectively. Elevated SACE pointed strongly towards 
the presence of sarcoidosis, although reservations must be made in patients with liver 
disorders, diabetes mellitus, hyperthyroidism, asbestosis or silicosis which are rather 
common disorders also associated with elevated SACE. Normal SACE does not exclude 
sarcoidosis. (Shultz T, 1979) 
Enzyme activity is higher SACE in patients with pulmonary involvement and changes in 
SACE are correlated to the roentgenological changes. It has been observed that among 
healthy controls, significantly higher SACE levels were found in children up to 17 years of 
age (21.2-42.2 U/ml) than in adults aged 18-65 years (12.0-36.8 U/ml). (Kiminobu 
Tanizawa,2010). In another study, the correlation between S-angiotensin-converting enzyme 
and disease activity was examined in 185 observation periods in 85 untreated sarcoidosis 
patients. An agreement between SACE and chest roentgenographic changes was found in 
42% of the observations. The most convenient interval between enzyme measurements 
seems to be 3 months in patients with active disease. Therefore, it can be interpretated that 
the pattern of enzyme variation may be a prognostic indicator in sarcoidosis. (Yamauchi M 
et al., 1997) 
5. IMAGING- Gallium-67 imaging has been widely used in the diagnosis of sarcoidosis. 
Gallium-67 is usually taken up in lesions with increased blood flow, typically in lesions 
of inflammatory origin. In sarcoidosis, a characteristic pattern of uptake in the chest has 
been described as the “lambda sign:” (paratracheal and bilateral hilar uptake) and the 
“panda sign,” caused by uptake in the lacrimal and parotid glands. (J.T.Annema et al., 
2005) Conventional monitors of the activity of pulmonary sarcoidosis, such as blood 
studies, pulmonary function testing, and chest roentgenograms, do not show as much 
as assessed by bronchoalveolar lavage or by histopathologic studies. 
6. ROLE OF ENDOSCOPY- In March 2009, a large international randomized clinical 
study “Trial for the Diagnosis of Sarcoidosis (GRANULOMA)” was started. This phase 
III study investigates two different diagnostic strategies for patients with suspected 
stage I/II pulmonary sarcoidosis. Bronchoscopy was done for 121 patients with 
establishing the definite diagnosis of sarcoidosis in 57 cases (42%). EUS-FNA was used 
for diagnosis of sarcoidosis and had a yield of 82% and sensitivity of 89–94% by 
assessing noncaseating granulomas in mediastinal nodes. In 72 cases, EUS-FNA/ 
EBUS-TBNA was performed, yielding a definite diagnosis in 47 (59%). Endoscopic 
ultrasound prevented a surgical procedure in more than half of these patients. (Julita 
Stępień1,2010) 
Thus, Endoscopic ultrasound-guided fine-needle aspiration has a high yield in diagnosing 
sarcoidosis. Endoscopic ultrasound-guided fine-needle aspiration will also reduce the 
number of mediastinoscopies.  
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The only abnormal finding in laboratory studies was a slightly elevated ESR (to 14 mm/h, 
normal range: 0–10 mm/h) In a study by Steinfort et al., which analysed lymph node lesions 
in patients suffering from non-small cell lung cancer, a sarcoid-like reaction was observed in 
8 out of 187 patients who had previously undergone thoracoscopy, lobectomy, or 
pneumonectomy and in 1 out of 50 patients who had undergone endobronchial ultrasound 
as part of the diagnostic evaluation for cancer. The authors emphasised that the lymph 
nodes in which sarcoid tissue was found revealed no tumour cells. 
7. ROLE OF AMYLOID- A role of serum amyloid A (SAA) in pathogenesis of 
granulomatous inflammation of sarcoidosis has recently been reported. Serum 
concentrations of SAA are significantly higher in sarcoidosis patients. The results of 
some studies have suggested suggest that serum amyloid A could be a suitable marker 
of sarcoidosis:, the protein is only expressed in gels of sarcoidosis patients and not in 
healthy subjects, and the SAA1 isoforms could match the biomarker of sarcoidosis 
reported previously. Further studies on a larger scale are required to understand  the 
effectiveness of SAA as a clinical biomarker of sarcoidosis.(Bässler R,1988) During the 
past decade, advances have been made in the study of sarcoidosis. The multicenter 
ACCESS (A Case Control Etiologic Study of Sarcoidosis) trial recruited > 700 subjects 
with newly diagnosed sarcoidosis and matched control subjects. They were unable to 
identify a single cause of sarcoidosis, but the Mycobacterium tuberculosis catalase-
peroxidase protein has been identified as a potential sarcoidosis antigen. Sarcoidosis 
remains a diagnosis of exclusion most reliably by a tissue biopsy specimen 
demonstrating non-caseating granulomas in a patient with additional clinical and 
radiologic features of the disease. The tumor necrosis factor inhibitors, a relatively new 
class of agents, have been used in some patients. The diagnosis of sarcoid  like 
reactions may be problematic because other known causes of granulomatous 
inflammation need to be excluded.  
4. Histopathology   
Histopathological examination of the involved organ is considered to be the most reliable 
method of diagnosis of Sarcoid like reaction. Sarcoid granulomas characterictically comprise 
of   collections of numerous epithelioid cells along with many multinucleated giant cells. 
These giant cells can be of two types; either Langhans giant cells or foreign body type of 
giant cells. Another pathognomic feature of a sarcoid granuloma is the presence of inclusion 
bodies within the multinucleated giant cells; lamellated calcified masses named: the 
Schaumann bodies and the star shaped asteroid bodies.  
Tumor-related sarcoid reactions have generally been reported to be in the lymph nodes 
draining regions with a malignancy disease, or in the parenchyma around the tumor. (Klein 
M,1994) The induction and evolution of granuloma formation results from a complex 
interplay between different cell populations, cytokines, and chemokines. Genetic 
polymorphisms may also influence the clinical expression of the granuloma formation and 
the prognosis of the disease. Sarcoid reactions in lymph nodes with or without metastasis 
from a primary malignant neoplasm are well-known. However, it is extremely rare to find 
these reactions associated with cutaneous solid tumors; only one such case has appeared in 
the literature. In a patient with cutaneous squamous cell carcinoma  sarcoid reactions and 
metastatic foci in the regional lymph nodes were also associated. The possibilities of 
systemic sarcoidosis and tuberculosis were excluded after extensive examinations specific 
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for these diseases. Some authors regard the sarcoid reaction to be a sign of a good prognosis 
on the basis of studies of a few patients with solid tumors. However, systematic analysis of a 
sufficient number of cases should be carried out to evaluate the clinical significance of this 
type of reaction. (Okabe T, 2002)  In some cases of invasive ductal and lobular carcinoma of 
the breast multiple epithelioid and giant cell containing granulomas were detected. These 
granulomas occurred as sarcoid-like lesions in uni- and bilateral primaries, in a recurrent 
tumour, and also in axillary lymph nodes. Histopathologically, these granulomas are not 
quite uniform, some of them show classic features of sarcoidosis, while others show marked 
proliferations of epithelioid or giant cells. The granulomas contain fibrinoid exudate or areas 
of necrosis and are  surrounded by dense infiltrates of mononuclear cells. Pathogenetically, 
these are reactions in the tumour stroma of varying intensity, and are caused by T-cell 
mediated immune response to an carcinoma antigen. (Brincker H, Pedersen NT,1991).                          
In sarcoidosis, unknown antigen(s) causes Th1-mediated granulomatous inflammation with 
cytokines such as IFN gamma and IL-12, initially. Furthermore IL-16, IL-8, IP-10 and 
RANTES also play a role in the accumulation of CD4+ T cell population. For the chemotaxis 
of macrophages and monocytes, factors like MCP-1, MIP1-alpha and RANTES are 
considered responsible.Local proliferation of T cell is induced by IL-2 and IL-15 and that of 
macrophage/monocyte lineage is done by M-CSF, GM-CSF and G-CSF as in cases of other 
inflammatory reactions. Removal of the antigen downregulates the immune response via 
TGFǃ and suppresses granuloma formation. Failure of removal of antigen can induce 
persistence of granuloma and irreversible fibrosis. (Spiteri MA et al., 1989) 
 
 
 
Fig. 1. A Sarcoid granuloma with Schaumann bodies within the multinucleated giant cells. 
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The pulmonary production of IFN-inducible protein (IP-10), a CXC chemokine that 
stimulates the directional migration of activated T cells. When compared to control subjects, 
excessively high levels of  IP-10 are demonstrated in the bronchoalveolar lavage (BAL) fluid 
of patients with pulmonary sarcoidosis . In a study a positive correlation was also 
demonstrated between IP-10 levels and the number of sarcoid cells in the BAL. 
Immunochemistry was performed with an anti-human IP-10 polyclonal Ab in lymph nodes 
showing  sarcoid granulomas. It was observed that cells bearing IP-10 were mainly 
epithelioid cells and CD68+ macrophages located inside granulomatous areas.In addition, 
alveolar lymphocytes recovered from patients with active sarcoidosis were CD4+ T cells 
expressing Th1 cytokines (IL-2 and IFN-gamma) and high levels of CXCR3. All these facts 
suggest the potential role of IP-10 in regulating the migration and activation of T cells 
toward sites of sarcoid inflammatory process and the subsequent granuloma formation. (Kin 
T, 1999)   
According to a study, granulomas can be divided into two main "families" according to the 
presence or absence of B cells within the granulomas: one is a B-cell-negative 
familycomprising of sarcoidosis and mycobacterial infection; the other is a B-cell-positive 
family comprising of  tumor-related sarcoid reactions, toxoplasmosis and other 
granulomatous lesions of unknown significance.   
Sometimes in patients with squamous cell carcinoma of lung, histopathological examination 
of hilar and mediastinal drainage lymph nodes show many non-caseating epithelioid cell 
granuloma even in absence of metastasis. Co-existence of sarcoidosis and lung cancer in the 
same patient is not common, and only 29 cases, have been reported. even if bilateral 
mediastinal lymphadenopathy is found in a case of lung cancer complicated with 
sarcoidosis, surgical tumor resection should be considered  
One such case of lower esophageal cancer was reported  where a lower esophagectomy with 
a total gastrectomy was performed. A sarcoid-like reaction within lymph nodes can occur 
even after few year of resection of the tumour. 
In some cases, the histological examination may show non-caseous epithelioid granulomas 
without necrosis in association with moderately differentiated carcinoma without any 
metastases to the regional lymph nodes; These changes should be considered to be sarcoid 
reactions, if no other physiological and laboratory findings compatible with systemic 
sarcoidosis are observed. Such histological findings sugges the possibility that the regional 
lymph nodes are not involved with the tumor cells at the time of diagnosis of cancer.  
The granulomas are present in a lymphatic pattern around bronchovascular structures and, 
because of this, may show angioinvasion. The bronchial involvement produces a high 
diagnostic yield for transbronchial and endobronchial biopsies in this disease. Finally, small 
amounts of fibrinoid necrosis may occur within granulomas of sarcoidosis and do not 
exclude the diagnosis. A number of cytoplasmic structures/inclusions can be identified 
within the granulomas of sarcoidosis, including asteroid bodies, Schaumann's bodies, 
calcium oxalate crystals, and Hamazaki-Wesenberg bodies; the last two of these can cause 
difficulties in differential diagnosis. Extra-pulmonary sarcoid can be an important factor in 
prognosis. Involved sites include (in decreasing frequency) skin, endocrine organs, extra-
thoracic lymph nodes, neurologic sites, eyes, liver, spleen, bone marrow, cardiac, 
ear/nose/throat, parotid/ salivary, muscles, bones/joint, and kidney. 
The association of soft tissue sarcomas with a granulomatous reaction is very rare, although 
a case of Kaposi sarcoma containing sarcoid-like granulomas has also been reported. In 
addition to vascular proliferation, and extravasated erythrocytes numerous spindle cells 
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were observed. These areas were surrounded by non-caseating granulomas. The patient had 
no clinical or laboratory findings of sarcoidosis. As mentioned earlier the granulomatous 
reaction is reported to be a good prognostic indicator in several carcinoma types but its 
importance in sarcomas is not clear.Another unusual type of codition is coexistence of 
sarcoid-like reaction with synovial sarcoma. There have been no such reported cases in 
literature. Therefore, understanding this kind of cases and their pathogenesis may help to 
improve the understanding of the relationship between malignancy and sarcoid-like 
reactions. 
 
 
 
Fig. 2. A cervical lymph node showing non-caseating granulomas comprising of  collections 
epithelioid cells and multinucleated giant cells in the background of Lymphocytes. 
The authors report a case of Hodgkin's disease associated with pulmonary and mediastinal 
sarcoidosis, and the frequency of sarcoid reactions in lymphoma, notably in Hodgkin's 
disease. The Hodgkin's disease-sarcoidosis association is much less common and sometimes 
raises difficult diagnostic problems. (Agostini Cet al.,1998) 
Electron microscopic examination of epithelioid-cell granulomas of has revealed a 
morphologic polarization of epithelioid cells, manifesting as 4 zones: crimped [correction of 
chimp] edge zone, zone of vesicles and vacuoles,  basal zone and osmiophilic granules zone. 
The structure of epithelioid cells in sarcoidosis and in sarcoid reactions  are found to be 
similar. Sarcoid epithelioid cells are believed to be a variant of tissue macrophages, which 
are derived from circulating monocytes in blood. It is a known fact that formation of 
monocytes and macrophages is controlled by hematopoietic growth factors, i.e.; colony-
stimulating factors in the bone marrow. In the presence of colony-stimulating factors and 
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vitamin D3, blood monocytes can proliferate and differentiate into epithelioid cells and 
multinucleated giant cells. Recent observations have shown that sarcoid granulomas 
themselves produce colony-stimulating factors and vitamin D3 which stimulate the 
proliferation and differentiation of circulating monocytes into macrophage-epithelioid cells. 
This also leads to formation of new sarcoid granulomas. 
Regarding the association of malignancy with sarcoidosis, various possibilities have been 
proposed to explain the occurrence of malignancy in sarcoidosis, namely, the occurrence of 
these two disorders together being a coincidence; sarcoidosis initiating the carcinogenesis or 
promoting the growth of malignancy via suppression of cellular immunity; and sarcoidosis 
occurring as a result of host immunological response against malignancy. However, in the 
absence of systemic involvement, the diagnosis is suggestive of a sarcoid reaction associated 
with a malignancy, rather than sarcoidosis. 
In addition to the pathognomic, asteroid and Schaumann bodies ,reactive hyperplasia 
within the Lymph nodes can also be observed. This could be explained on the basis of 
specific cell mediated immune response against the soluble antigenic factors derived from 
the tumor cells by both activated macrophages and T lymphocytes. Thus the granulomatous 
reaction and subsequent release of cytokines such as TNF-ǂ, IL-2 and IL-8 might be a 
marker of an immunologically mediated anti-tumor response.  
Three possible mechanisms are offered for the mode of formation of asteroid bodies, namely 
phagocytosis and partly fused cell membranes; trapping and polymerization of collagen 
within incompletely fused epitheloid cells; and transformation of epitheloid cells into 
fibroblasts during the healing of granulomas. The latter possibilityof epithelioid cells being 
transformed into fibroblasts, is favored but requires more evidence in support of fibroblastic 
potentiality of epitheloid cells and macrophages 
The mechanism of the formation of Schaumann bodies can be explained on the basis of 
different concepts.Most of the authors who have previously examined these structures have 
considered them to be products of degeneration of elastic fibrils impregnated with calcium 
and iron salts. Schaumann advanced the opinion that tubercle bacilli can be transformed 
into such bodies. It is also believed that these bodies may result from deposition around 
elastic fibrils, connective tissue fibrils, or hair resulting from disintegrated tubercle bacilli 
and proposed that they are products of intracellular globulin precipitate.  
Sarcoid granulomata result from aberrant immunological reactions initiated by antigen--
presenting macrophage--like cells, and maintained by other effector macrophages. These 
macrophages can be distinguished phenotypically by monoclonal antibodies RFD1 and RFD7 
(which recognize dendritic cells and mature macrophages respectively). A study has shown 
that active sarcoid BAL contains a high proportion of RFD1 + cells (mean 44.7% compared to 
12% in normals). Furthermore it has been demonstrated that gamma-interferon, produced in 
high concentration by activated T-lymphocytes induces not only HLA-DR molecules on cells, 
but has also been shown in vitro to increase the proportion of RFD1+ cells but suppressing 
RFD7 expression. Therefore,It  seems that the increased proportion of RFD1+ D7+ 
macrophages seen in active sarcoidosis could arise as a result of an increased induction of 
RFD1 expression on macrophages which express RFD7. (Sugio K, 1993) 
5. Differential diagnosis  
The first step in getting correct treatment is to get a correct diagnosis. Granulomas have also 
been observed within the lymph nodes associated with other granulomatous diseases. 
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Differential diagnosis list for Sarcoidosis may include: berylliosis, tuberculosis, 
hypersensitivity pneumonitis (farmer's lung disease), Fungal infections, Rheumatoid arthritis,  
Rheumatic fever, Lymphoma, Histoplasmosis, Coccidioidomycosis, Idiopathic pulmonary 
fibrosis, Pneumoconiosis, Syphillis. In 1994, Leibow first described a condition termed; 
Necrotizing sarcoid granulomatosis (NSG). Based on radiological and clinical features, it was 
concluded that NSG is the histopathological variant of sarcoidosis, also termed "nodular 
sarcoidosis. Necrotizing sarcoid granulomatosis has been reported in 1.6% to 4% of patients 
with sarcoidosis. Although it comprises of sarcoid-like granulomas, they are associated with 
granulomatous pneumonitis, variable amounts of necrosis and granulomatous vasculitis. 
Radiographic nodules made up of multiple granulomas are also found. 
Common variable immunodeficiency (CVID) is a disorder characterized by 
hypogammaglobulinemia, poor antibody responses and recurrent bacterial infections. CVID 
patients have a higher prevalence of autoimmune disease and some of them develop 
noncaseating granulomas of the lungs, spleen, liver, skin, lymph nodes and eye. In patients 
with CVID, different types of autoimmune disease could be seen. Therefore, these patients 
should be carefully evaluated for diseases other than sarcoidosis. 
An anti-Kveim monoclonal antibody, IHY-1,was developped which reacts with sarcoid 
granulomas as well as with epithelioid cells of various granulomatous diseases including 
tuberculosis. Thus differentiation of Sarcoid grnulomas with granulomas of other conditions 
was difficult. Recently, 2 new anti-Kveim monoclonal antibodies, IHY-2 and IHY-3 were  
developed which reacted with epithelioid cells in sarcoidosis but not in tuberculosis. 
Immunoperoxidase technique was used and it was observed that these antibodies reacted 
with most epithelioid cells in sarcoid granulomas, confirming the fact that that these cells 
expressed the antigen present in the Kveim reagent. (Balamurugan S, 2009) 
Granulomatous reactions have been reported in association with lymphomas, more often 
with Hodgkins disease than with Non-Hodgkins Lymphoma. Not many reports are 
available on the association of anaplastic large-cell lymphoma with sarcoid-type granuloma. 
It is suggested that a detailed clinical history, careful histological examination and 
immunohistochemistry helped in attaining the correct diagnosis. 
Problems may also arise of distinguishing between tumour-related sarcoid reactions and 
true systemic sarcoidosis. As mentioned earlier ,the diagnosis of sarcoidosis is based more 
on exclusion criteria and thorough clinical and radiological investigations are required to 
differentiate it from sarcoid like reactions.  This differentiation is essential for further 
treatment planning and prevention of recurrence of disease. Most probably, sarcoid 
reactions are caused by antigenic factors derived from the tumour cells, eliciting an 
immunological hypersensitivity reaction leading to the formation of epithelioid-cell 
granulomas. Sarcoid reactions may be a marker of an immunologically mediated anti-
tumour response of macrophages activated by T-lymphocytes, and in Hodgkin's disease 
there is evidence that patients with sarcoid reactions have a better prognosis. Sometimes, 
sarcoid reactions may be so extensive that they complicate the diagnosis of an underlying 
malignant disease.  
Previous reports indicate that enlarged hilar and mediastinal lymph nodes caused by 
sarcoid-like reactions may develop after curative resection of cancer. This presence does not 
indicate recurrence. Reports further suggest that coexisting pulmonary infiltrates in this 
setting may be related to sarcoidosis. In a study, two patients who had resected lung and 
gastric cancer and who later developed pulmonary interstitial infiltrate, concurrent with 
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progressive mediastinal lymphadenopathy initially thought to be caused by intrathoracic 
dissemination of their cancer. These changes were shown by open lung biopsy to be a 
benign, granulomatous reaction interpreted as sarcoidosis. Thus, it is important to recognize 
this clinical pattern when pulmonary infiltrates develop after complete treatment of cancer 
in an otherwise relapse-free patient and to encourage lung or lymph node biopsy in these 
particular settings in order to confirm a sarcoid-like reaction, thereby avoiding unnecessary 
chemotherapy for presumed tumor recurrence. 
During microscopic examination of sections of lymph nodes, it may give an appearance of a 
metastatic node with numerous collections of tumour cells. But careful observation may 
reveal that they are actually epithelioid cells with presence of other pathognomonic features 
of sarcoid granulomas like, presence of Schaumann bodies and asteroid bodies. Further 
confirmation of sarcoid like reaction requires ruling out of any systemic involvement by 
radiographs, ACE level assessment and other investigation procedures which are specific 
for sarcoidosis. 
6. Treatment  
A standard treatment with immune suppressants such as glucocorticoids should be started. 
In some of the patients recover spontaneously without any treatment. In other patients, a 
treatment is necessary during the follow-up course. Immunosuppressive drugs like 
hydroxychloroquine and infliximab may be useful in some patients. Treatment should be 
continued at least for about one year. Initially, patients should receive prednisone or 
prednisolone at 0.5 to 1 mg/kg daily for 6 to 12 weeks to obtain a complete remission, and 
then later followed by a gradual dose reduction every 6 to 12 weeks. The follow up should 
be carried out for about three years. When corticosteroids are contraindicated, methotrexate 
and azathioprine in low doses are the most useful immunosuppressive drugs. 
Hydroxychloroquine and chloroquine are indicated in extensive skin lesions or as 
corticosteroids sparing agents. Recent advancements in the field of Biotechnology has 
resulted in new treatment stratagies like use of monoclonal antibodies. In patients with 
sarcoidosis, only the use of monoclonal antibodies that block tumour necrosis factor (TNF) 
has been studied scientifically and at present, TNF-blockers are used in patients with 
therapy refractory sarcoidosis 
In a Literature review, accessed through MEDLINE (1966-August 2002), OVID (2001-
January 2003), and bibliographic searches, the use of infliximab in the treatment of 
sarcoidosis was evaluated. It was observed that, tumor-necrosis factor-alpha blockade 
appeared to be a suitable strategy for treating sarcoidosis. Since the evidence for above 
concept is not sufficient, further data are required to establish the role of infliximab.(Serio 
PN,2003) 
7. Prognosis 
of sarcoidosis is often good. About 60-70% cases heal spontaneously within 24-36 months 
and fatal complications are observed only in 5-10% of patients which may be due to 
respiratory involvement. Estimated mortality rate for sarcoidosis from prevalence and 
deaths statistics  is 20 per 100,000 overall; 5 in 100,000 white people; 40 out of 100,000 black 
people; Scandinavia 64 out of 100,000 people. The ratio of deaths to prevalence is 1.1%. As 
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far as sarcoid like reactios are considered, the resection of the tumour to which it is 
associated and the related surgical treatment of the involved organ and, would be sufficient 
to restore patient’s normal condition. It is considered that granulomatous sarcoid-like 
lesions are indicative of an immunologically mediated antitumor response of macrophages 
activated by T lymphocytes. Thus leading to a favorable prognosis. 
8. Conclusion  
The diagnosis of sarcoidosis, could be difficult; in fact typical laboratory findings of 
sarcoidosis such as ACE, lysozyme, calcium, sometimes may not be diagnostic. 
Ultrasonography and CT are important but the diagnosis is mainly established only with the 
histological examination of suspected lesions. As it is not possible to distinguish sarcoid- 
like reaction from sarcoidosis only histologically, a thorough investigation of the patient is 
mandatory to rule out systemic sarcoidosis or other granulomatous diseases. The concept of 
correlation between various types of malignancies and sarcoid-like reaction and sarcoidosis 
is still unclear. Further studies are required to explain this concept more accurately.  
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